AVAH (Aveanna Healthcare Holdings) 5-Year EBITDA Growth Rate: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AVAH Aveanna Healthcare Holdings Inc AVAH
63 GF Score
Price $9.46
GF Value $5.19
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Aveanna Healthcare Holdings 5-Year EBITDA Growth Rate?

Aveanna Healthcare Holdings AVAH +1.01% 63 5-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus rates AVAH with a GF Score™ of 63/100 and a GF Value™ of $5.19 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Aveanna Healthcare Holdings's EBITDA per Share for the three months ended in Mar. 2026 was $0.36.

During the past 12 months, Aveanna Healthcare Holdings's average EBITDA Per Share Growth Rate was 41.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of Aveanna Healthcare Holdings was -15.50% per year. The lowest was -15.50% per year. And the median was -15.50% per year.


Aveanna Healthcare Holdings  (NAS:AVAH) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Aveanna Healthcare Holdings 5-Year EBITDA Growth Rate Related Terms


AVAH vs SGRY, ASTH, ADUS: 5-Year EBITDA Growth Rate Comparison

For the Medical Care Facilities subindustry, Aveanna Healthcare Holdings's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aveanna Healthcare Holdings 5-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Aveanna Healthcare Holdings's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Aveanna Healthcare Holdings's 5-Year EBITDA Growth Rate falls into.


AVAH
63GF Score
Aveanna Healthcare Holdings Inc AVAH
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aveanna Healthcare Holdings 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 0.00% mean?
Aveanna Healthcare Holdings (AVAH) has a 5-Year EBITDA Growth Rate of 0.00% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Aveanna Healthcare Holdings and its competitors.
Is Aveanna Healthcare Holdings' 5-Year EBITDA Growth Rate too high?
Aveanna Healthcare Holdings' current 5-Year EBITDA Growth Rate is 0.00%. Overall, Aveanna Healthcare Holdings has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aveanna Healthcare Holdings' 5-Year EBITDA Growth Rate compare to SGRY and ASTH?
Aveanna Healthcare Holdings' 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
A good 5-Year EBITDA Growth Rate depends on the Healthcare Providers & Services industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Aveanna Healthcare Holdings and its competitors. Aveanna Healthcare Holdings's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aveanna Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Aveanna Healthcare Holdings (AVAH) is currently considered Significantly Overvalued. The stock's GF Value™ is $5.19, compared to a current price of $9.46 — trading 82.2% above its estimated fair value. The current 5-Year EBITDA Growth Rate is 0.00%. Aveanna Healthcare Holdings' overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Aveanna Healthcare Holdings (AVAH), the current 5-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aveanna Healthcare Holdings (AVAH) Overvalued in 2026?

Based on GuruFocus' analysis, Aveanna Healthcare Holdings stock appears to be overvalued. The current stock price of $9.46 is trading 82.2% above its estimated GF Value™ of $5.19. GuruFocus considers Aveanna Healthcare Holdings to be Significantly Overvalued.

Key valuation signals for AVAH:

  • 5-Year EBITDA Growth Rate: 0.00%
  • GF Value™: $5.19 vs. price of $9.46 (82.2% above fair value)
  • GF Score™: 63/100 with 6 warning signs

No single metric tells the full story. See the AVAH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aveanna Healthcare Holdings Business Description

Address 400 Interstate North Parkway SE, Suite 1600, Atlanta, GA, USA, 30339
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.
63GF Score

Get the complete analysis for AVAH

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.46
Price
$5.19
GF Value